Document Detail


Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells.
MedLine Citation:
PMID:  17669439     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The aim of the present study is to investigate the effect of histone deacetylase inhibitor, trichostatin A (TSA) on the cell growth, apoptosis, genomic DNA damage and the expression of telomerase and associated factors in human normal and brain cancer cells. Here, human normal un-transformed fibroblasts (MRC-5), human normal hTERT-immortalised fibroblasts (hTERT-BJ1) and human brain cancer cell lines (glioblastoma cell line, A-172 and medulloblastoma cell line, ONS-76) were treated with 0.5-3.0microM TSA for 24h. Exposure to TSA resulted in apoptosis in a dose-dependent manner in the brain cancer cells. Glioblastoma cell line (A-172) displayed higher sensitivity to TSA-induced cell killing effect and apoptosis than the medulloblastoma cell line (ONS-76). The brain cancer cell lines and hTERT-BJ1 cell line displayed significant inhibition in telomerase activity and hTERT mRNA level after 2microM TSA treatment. Elevated expressions of p53 and p21 with a decrease in cyclin-D level supported the observation on cell cycle arrest following TSA treatment. Upregulation of Bax and cytochrome c correlated with the apoptotic events in TSA-treated cells. This study suggests that telomerase and hTERT might be the primary targets of TSA which may have the potential to be used as a telomerase inhibitor in cancer therapy.
Authors:
Aik Kia Khaw; Miranti Silasudjana; Birendranath Banerjee; Masao Suzuki; Rajamanickam Baskar; M Prakash Hande
Related Documents :
15479119 - Spontaneous cell transformation: karyoplasts derived from multinucleated cells produce ...
11148139 - Telomere associations in interphase nuclei: possible role in maintenance of interphase ...
11714789 - Evidence for a compartmentalized b cell response as characterized by igg epitope specif...
12496279 - Evidence that high telomerase activity may induce a senescent-like growth arrest in hum...
20816839 - Hiv-tat-mediated delivery of an lpts functional fragment inhibits telomerase activity a...
7976059 - Retardation of cell aging by lipid peroxidation. ii.
21501369 - The thermolysin-like metalloproteinase and virulence factor lasb from pathogenic pseudo...
3027239 - Reassortment of human rotavirus possessing genome rearrangements with bovine rotavirus:...
3731389 - Quantitative light microscopic study on the distribution of kupffer cells during chemic...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2007-06-26
Journal Detail:
Title:  Mutation research     Volume:  625     ISSN:  0027-5107     ISO Abbreviation:  Mutat. Res.     Publication Date:  2007 Dec 
Date Detail:
Created Date:  2007-11-05     Completed Date:  2007-12-13     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0400763     Medline TA:  Mutat Res     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  134-44     Citation Subset:  IM    
Affiliation:
Genome Stability Laboratory, Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Republic of Singapore.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apoptosis / drug effects
Brain Neoplasms / drug therapy*,  enzymology,  genetics,  pathology
Cell Cycle / drug effects
Cell Line, Tumor
Cell Proliferation / drug effects
Cell Survival / drug effects
DNA Repair
DNA Replication / drug effects
Gene Expression / drug effects
Genomic Instability / drug effects,  physiology
Histone Deacetylase Inhibitors*
Humans
Hydroxamic Acids / pharmacology
In Situ Hybridization, Fluorescence
RNA, Messenger / genetics,  metabolism
RNA, Neoplasm / genetics,  metabolism
Telomerase / antagonists & inhibitors*,  genetics
Chemical
Reg. No./Substance:
0/Histone Deacetylase Inhibitors; 0/Hydroxamic Acids; 0/RNA, Messenger; 0/RNA, Neoplasm; 58880-19-6/trichostatin A; EC 2.7.7.49/Telomerase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Bystander response in human lymphoblastoid TK6 cells.
Next Document:  Simultaneous assessment of the effects of L-type current modulators on sensory and motor pathways of...